P
Power Law company profile
PolyNovo
Biotech & Life Sciences · Melbourne, Australia · Founded 1998 · IPO 1999 Unicorn
Valuation
$964M
Market cap · 2026
Revenue
$68M
Latest reported FY
Patent intelligence
$15M patent portfolio · 7 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$15M
1.5% of market cap · 27.8× smaller than top peer NovoCure ($409M)
7 active patent families
Where PolyNovo innovates
Polymer chemistryBiodegradable polyurethaneTissue engineeringBiodegradationBiomedical engineering
Above peer median on Market · Below peer median on Strategic
Quality vs same-sector peers
PolyNovo on the five Patsnap quality dimensions
PolyNovo in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where PolyNovo concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across PolyNovo and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee PolyNovo on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.